Rituximab Use for the Treatment of Childhood Nephrotic Syndrome by Canadian Pediatric Nephrologists: A National Survey

BACKGROUND: There is known practice variation in the treatment of frequently relapsing, steroid-dependent, and steroid-resistant nephrotic syndrome in children. Rituximab is an emerging therapy for difficult-to-treat nephrotic syndrome; however, there are no clear treatment guidelines. We therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Meeuwisse, Cory, Morgan, Catherine J., Samuel, Susan, Alexander, R Todd, Rodriguez-Lopez, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Clinical Research Qualitative
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922210/
https://www.ncbi.nlm.nih.gov/pubmed/35300066
http://dx.doi.org/10.1177/20543581221079959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922210/
https://www.ncbi.nlm.nih.gov/pubmed/35300066
http://dx.doi.org/10.1177/20543581221079959

Ejemplares similares